Stock market update: Stocks that hit 52-week lows on NSE in today's tradeTata Motors, Sun Pharma, Eicher Motors, Bharti Airtel and Kotak Bank were among the top losers on NSE in today's trade.
Stock market update: Stocks that hit 52-week highs on NSE in today's tradeCura Tech, AB Infrabuild, Aavas Financiers, Gujarat Themis and Shree Cements, hit their fresh 52-week highs during the day.
Stock market update: Stocks that hit 52-week highs on NSEAB Infrabuild, Setco Automotive, Shree Cements and Chambal Fertilisers, hit their fresh 52-week highs at 10:41AM.
Stock market update: Stocks that hit 52-week lows on NSETata Motors, Sun Pharma, Dr. Reddys, IndusInd Bank and Eicher Motors were among the top losers on NSE.
Stocks in news: Ambuja Cement, Alivus Life, Route Mobile, Aurobindo Pharma, LTIMindtreePiramal Enterprises announced that the administrative committee of its board of directors will meet on December 20 to consider public issua...
Promoters to offload over 11% stake in Aditya Birla Sun Life via OFS on March 19-20Aditya Birla Sun Life AMC promoters to sell stake via OFS to meet 25% public float rule. Sebi mandates compliance for all listed companies....
Stocks in news: TCS, L&T Finance, AB Sun Life, Tata Steel, P&G IndiaThe Board of L&T Finance Holdings approved raising of Rs 1.01 lakh crore through issuance of non-convertible debentures in one or more tran...
Devil's Comet: Can you spot the 'Eclipse Comet' with the naked eye? Here's when to watchBigger in size than Everest, this comet orbits the sun almost every 71 years.
Aditya Birla Capital soars on MF arm ‘listing’ plansThe share sale in Aditya Birla Sun Life Asset Management Company will unlock value in the financial services company belonging to the Adity...
Stock market update: Nifty Pharma index gains 2%; Sun Pharma jumps 5%The index was trading 1.98 per cent up at 11585.5.
Stock market update: Nifty IT index surges 500 points! Coforge climbs 4%The index was trading 2.47 per cent up at 21249.15.
Aditya Birla Mutual Fund suspends fresh inflows in two debt schemesRedemptions from these funds, though, will be allowed, as usual.
‘Retail investors may skip AB Sun Life’s Pharma NFO’This is the fifth new fund offer in the pharma and healthcare space in the last one year.
Birla, Kotak look to pick 24% stake in Max FinancialSources say AB Capital has evinced an interest to buy 24% stake in Max Financial
Aditya Birla Group rejig may lead to Grasim-Nuvo mergerTwo-step recast may involve merger of Grasim and parts of AB Nuvo, followed by hiving-off of Nuvo’s finance services business into separate...
- RBS initiates coverage on Aditya Birla Nuvo with a 'Buy' rating
RBS initiates coverage on Aditya Birla Nuvo with a `Buy’ rating and target price of Rs 1,050 per share.
- AB Nuvo may hive off financial services biz
Aditya Birla Group is looking at carving out the financial services business from group company AB Nuvo to unlock value and realise economi...